Thomson Mary Christina 4
4 · Sierra Oncology, Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Thomson Mary Christina
General Counsel, CCO & Sec'y
Transactions
- Exercise/Conversion
Common Stock
2022-02-04$13.04/sh+2,000$26,080→ 2,000 total - Sale
Common Stock
2022-02-04$29.78/sh−2,000$59,560→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-02-04+2,000→ 0 totalExercise: $13.04Exp: 2030-07-28→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 21, 2022. The Reporting Person is subject to a Lock-Up Letter Agreement that expires on April 26, 2022. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
- [F2]On July 28, 2021, the option vested as to 25% of the total shares granted on July 28, 2020, with the remaining shares from that grant vesting in equal monthly installments over the following 36 months, with 100% of the total shares vested on July 28, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.